Titre:
  • Health-related quality of life and disease symptoms in postmenopausal women with hr+, her2- advanced breast cancer treated with everolimus plus exemestane versus exemestane monotherapy
Auteur:Campone, Mario; Beck, Joseph Thaddeus; Gnant, Michael; Neven, Patrick; Pritchard, Kathleen; Bachelot, Thomas; Provencher, Louise; Rugo, Hope; Piccart-Gebhart, Martine; Hortobagyi, Gabriel N.; Nunzi, Martina; Heng, Daniel Y C; Baselga, José; Komorowski, Anna; Noguchi, Shinzaburo; Horiguchi, Jun; Bennett, Lee; Ziemiecki, Ryan; Zhang, Jie; Cahana, Ayelet; Taran, Tetiana; Sahmoud, Tarek; Burris, Howard H.A.
Informations sur la publication:Current medical research and opinion, 29, 11, page (1463-1473)
Statut de publication:Publié, 2013-11
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:Advanced breast cancer
Everolimus
Exemestane
Health-related quality of life
Hormone receptor positive
MeSH keywords:Adult
Aged
Androstadienes -- adverse effects -- therapeutic use
Antineoplastic Agents -- therapeutic use
Antineoplastic Combined Chemotherapy Protocols -- adverse effects -- therapeutic use
Breast Neoplasms -- drug therapy -- metabolism
Disease Progression
Disease-Free Survival
Female
Health Status
Humans
Immunosuppressive Agents -- therapeutic use
Middle Aged
Placebos -- therapeutic use
Quality of Life
Questionnaires
Receptor, ErbB-2 -- metabolism
Receptors, Estrogen -- metabolism
Receptors, Progesterone -- metabolism
Sirolimus -- adverse effects -- analogs & derivatives -- therapeutic use
Treatment Outcome
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0300-7995
info:doi/10.1185/03007995.2013.836078
info:scp/84885758013
info:pmid/23962028